Dashboard PDUFA PDUFA History Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...

Free public preview Track CMPS with free AI briefings, catalyst countdowns, and dilution alerts.

CMPS

FDA catalysts, PDUFA dates with approval probability, drug pipeline, cash runway and insider activity — updated automatically from SEC, FDA and ClinicalTrials.gov data.

$466M Cash on Hand

32.6mo Cash Runway

5.5% Short Interest

🧪 Upcoming Trial Catalysts

2026-06-30 · Phase 3 — Recruiting — The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Di
2028-11-01 · Phase 2, Phase 3 — Upcoming Trial — Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Pa

📊 Drug Pipeline

Drug	Indication	Phase	Status
Psilocybin	Major Depressive Disorder	PHASE3	RECRUITING
COMP360 psilocybin	PTSD - Post Traumatic Stress Disorder	PHASE2	NOT_YET_RECRUITING

💰 Cash Runway & Dilution Risk

CMPS holds $466M in cash and burns about $42.9M/quarter from operations, giving an estimated runway of 32.6 months. A recent offering filing was detected — dilution watch.

Source: SEC EDGAR XBRL (operating cash flow). Get dilution alerts for CMPS free →

📈 Recent Insider Activity (Form 4)

Date	Insider	Type	Value
2026-05-29	JONAS JEFFREY M	Purchase	$0
2026-05-29	SANTINI GINO	Purchase	$0
2026-05-29	Riley Wayne Joseph	Purchase	$0
2026-05-29	Norton David Y	Purchase	$0
2026-05-29	Gover Justin D.	Purchase	$0

Get the full CMPS picture

A free BioRadar account adds AI daily briefings, sentiment tracking, trial enrollment progress, and email alerts for CMPS and 2 more tickers of your choice.

Create Free Account →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z